Free Newsletter

FierceVaccines is a weekly update on the vaccine industry, with a special focus on the innovations revolutionizing the development and production of vaccines. Join thousands of lab research professionals who get FierceVaccines via weekly email. Sign up today!

About | View Sample | Privacy

Hottest Products

Compare Top Solutions in:

Evaluate more than 400,000 products >>

Featured Jobs

Principal Scientist
Watson Pharmaceuticals - Fort Lauderdale, FL
Partner
Lundbeckfond Ventures - Copenhagen, Denmark
Hematology Oncology Consultant, Hematology - Louisiana North Job
Celgene Corporation - Louisiana, LA, US
Clinical Research Coordinator
Lovelace Respiratory Research Institute - Albuquerque, NM
Director, IT Global Operation Services, End-User Informatics Job
Celgene Corporation - Summit, NJ, US

More Jobs >>

Events

Enforcement, Litigation and Compliance Conference
Dec. 6-7 — Washington, DC
Life Science in the Cloud
Nov 16, 2011 — Cambridge, MA
Just Released: New Trends in Preventive and Therapeutic Vaccine
Biomarker Applications for Improved Clinical Trial Outcomes
Nov. 15-16 — Boston

More Events >>

Related Tags >> Vaccine

analysts News

Most Popular analysts Story

Booming vax market will more than double by 2014

January 15, 2009 — 9:16am ET | By John Carroll

Analysts at Frost & Sullivan say the booming vaccines market will more than double in the seven years leading up to 2014. In a new report, the company says that novel vaccines and innovative Read more...

analysts Press Releases

G. Steven Burrill predicts what's ahead for biotech in 2009
Booz & Company Study Finds Top Corporate Spenders on R&D Boosted Investments to Nearly Half a Trillion Dollars in 2007

Latest Headlines

Booming vax market will more than double by 2014
January 15, 2009

Paid Research Reports

Trends in mHealth and Telemedicine
The Global Aesthetic Dermatology Market Outlook
Future Directions in Regenerative Medicine
Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline

More Research Reports >>

THE FIERCEMARKETS NETWORK